Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort.

Pop-Busui R, Lu J, Brooks MM, Albert S, Althouse AD, Escobedo J, Green J, Palumbo P, Perkins BA, Whitehouse F, Jones TL; BARI 2D Study Group.

Diabetes Care. 2013 Oct;36(10):3208-15. doi: 10.2337/dc13-0012. Epub 2013 Jun 11.

PMID:
23757426
[PubMed - indexed for MEDLINE]
2.

Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort.

Pop-Busui R, Lu J, Lopes N, Jones TL; BARI 2D Investigators.

J Peripher Nerv Syst. 2009 Mar;14(1):1-13. doi: 10.1111/j.1529-8027.2009.00200.x.

PMID:
19335534
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Favorable effects of insulin sensitizers pertinent to peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Althouse AD, Abbott JD, Sutton-Tyrrell K, Forker AD, Lombardero MS, BuitrĂ³n LV, Pena-Sing I, Tardif JC, Brooks MM; BARI 2D Study Group.

Diabetes Care. 2013 Oct;36(10):3269-75. doi: 10.2337/dc12-2265. Epub 2013 Jun 4.

PMID:
23735723
[PubMed - indexed for MEDLINE]
4.

Determinants of successful glycemic control among participants in the BARI 2D trial: a post-hoc analysis.

Ismail-Beigi F, Lombardero MS, Escobedo J, Genuth S, Green J, Massaro E, Mooradian AD, Ovalle F, Whitehouse F, Zonszein J; BARI 2D Study Group.

J Diabetes Complications. 2014 Jan-Feb;28(1):101-9. doi: 10.1016/j.jdiacomp.2013.01.006. Epub 2013 Mar 7.

PMID:
23478173
[PubMed - indexed for MEDLINE]
5.

Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).

Tamis-Holland JE, Lu J, Korytkowski M, Magee M, Rogers WJ, Lopes N, Mighton L, Jacobs AK; BARI 2D Study Group.

J Am Coll Cardiol. 2013 Apr 30;61(17):1767-76. doi: 10.1016/j.jacc.2013.01.062. Epub 2013 Feb 28.

PMID:
23500245
[PubMed - indexed for MEDLINE]
Free Article
6.

The effect of age on clinical outcomes and health status BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes).

Chung SC, Hlatky MA, Faxon D, Ramanathan K, Adler D, Mooradian A, Rihal C, Stone RA, Bromberger JT, Kelsey SF, Brooks MM; BARI 2D Study Group.

J Am Coll Cardiol. 2011 Aug 16;58(8):810-9. doi: 10.1016/j.jacc.2011.05.020.

PMID:
21835316
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A, Kennedy L, Monrad ES, Pop-Busui R, Kelsey SF, Frye RL; BARI 2D Investigators.

Circulation. 2013 Aug 20;128(8):785-94. doi: 10.1161/CIRCULATIONAHA.112.000678. Epub 2013 Jul 15.

PMID:
23857320
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Sobel BE, Hardison RM, Genuth S, Brooks MM, McBane RD 3rd, Schneider DJ, Pratley RE, Huber K, Wolk R, Krishnaswami A, Frye RL; BARI 2D Investigators.

Circulation. 2011 Aug 9;124(6):695-703. doi: 10.1161/CIRCULATIONAHA.110.014860. Epub 2011 Jul 18.

PMID:
21768545
[PubMed - indexed for MEDLINE]
Free Article
9.

Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group.

Am Heart J. 2008 Sep;156(3):528-536, 536.e1-5. doi: 10.1016/j.ahj.2008.05.015. Epub 2008 Jul 31.

PMID:
18760137
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM).

Azad N, Emanuele NV, Abraira C, Henderson WG, Colwell J, Levin SR, Nuttall FQ, Comstock JP, Sawin CT, Silbert C, Rubino FA.

J Diabetes Complications. 1999 Sep-Dec;13(5-6):307-13.

PMID:
10765007
[PubMed - indexed for MEDLINE]
11.

The Eurodiab study: what has this taught us about diabetic peripheral neuropathy?

Tesfaye S, Selvarajah D.

Curr Diab Rep. 2009 Dec;9(6):432-4. Review.

PMID:
19954687
[PubMed - indexed for MEDLINE]
12.

Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial.

Althouse AD, Abbott JD, Forker AD, Bertolet M, Barinas-Mitchell E, Thurston RC, Mulukutla S, Aboyans V, Brooks MM; BARI 2D Study Group.

Diabetes Care. 2014 May;37(5):1346-52. doi: 10.2337/dc13-2303. Epub 2014 Mar 4.

PMID:
24595631
[PubMed - in process]
13.

[Analysis of the related risk factors of diabetic peripheral neuropathy].

Nie C, Bao HP.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2012 Dec;26(6):467-9. Chinese.

PMID:
23627032
[PubMed - indexed for MEDLINE]
14.

Risk factor control for coronary artery disease secondary prevention in large randomized trials.

Farkouh ME, Boden WE, Bittner V, Muratov V, Hartigan P, Ogdie M, Bertolet M, Mathewkutty S, Teo K, Maron DJ, Sethi SS, Domanski M, Frye RL, Fuster V.

J Am Coll Cardiol. 2013 Apr 16;61(15):1607-15. doi: 10.1016/j.jacc.2013.01.044.

PMID:
23500281
[PubMed - indexed for MEDLINE]
Free Article
15.

Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.

Hlatky MA, Boothroyd DB, Melsop KA, Kennedy L, Rihal C, Rogers WJ, Venkitachalam L, Brooks MM; Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group.

Circulation. 2009 Dec 22;120(25):2550-8. doi: 10.1161/CIRCULATIONAHA.109.912709. Epub 2009 Nov 17.

PMID:
19920002
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Presentation in patients with angiographically documented coronary artery disease and type II diabetes mellitus (from the BARI 2D Clinical Trial).

Krishnaswami A, Hardison R, Nesto RW, Sobel B; BARI 2D Investigators.

Am J Cardiol. 2012 Jan 1;109(1):36-41. doi: 10.1016/j.amjcard.2011.08.004. Epub 2011 Sep 28.

PMID:
21958742
[PubMed - indexed for MEDLINE]
17.

Absence of clinical relationship between oxidized low density lipoproteins and diabetic peripheral neuropathy: a case control study.

Rosales-Hernandez A, Cheung A, Podgorny P, Chan C, Toth C.

Lipids Health Dis. 2014 Feb 12;13:32. doi: 10.1186/1476-511X-13-32.

PMID:
24520839
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study).

Pop-Busui R, Lombardero M, Lavis V, Forker A, Green J, Korytkowski M, Sobel BE, Jones TL; BARI 2D Study Group.

Am J Cardiol. 2009 Jul 1;104(1):52-8. doi: 10.1016/j.amjcard.2009.02.046. Epub 2009 May 13.

PMID:
19576321
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

[Curative effect of alpha-lipoic acid on peripheral neuropathy in type 2 diabetes: a clinical study].

Liu F, Zhang Y, Yang M, Liu B, Shen YD, Jia WP, Xiang KS.

Zhonghua Yi Xue Za Zhi. 2007 Oct 16;87(38):2706-9. Chinese.

PMID:
18167250
[PubMed - indexed for MEDLINE]
20.

[A comparison of clinical effectiveness of different neuropathy scoring systems in screening asymptomatic diabetic peripheral neuropathy].

Hu H, Li H, Zheng FP, Cheng Y, Miao J, Zhang W.

Zhonghua Nei Ke Za Zhi. 2012 Jan;51(1):13-7. Chinese.

PMID:
22490752
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk